0.00Open0.00Pre Close0 Volume0 Open Interest140.00Strike Price0.00Turnover0.00%IV-56.38%PremiumAug 16, 2024Expiry Date180.99Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.77Leverage Ratio--Theta--Rho--Eff Leverage--Vega
United Therapeutics Stock Discussion
lol that is a shit ton of inside selling all at the end of June
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3 ...
$CG Oncology (CGON.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Insmed (INSM.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Jaguar Health (JAGX.US)$ Phas...
🇺🇸 Texas Pacific Land $Texas Pacific Land (TPL.US)$ 63.3%
🇸🇪 Evolution $Evotec (EVO.US)$ 59.3%
🇺🇸 CME Group $CME Group (CME.US)$ 57.1%
🇺🇸 Visa $Visa (V.US)$ 55.3%
🇬🇧 Rightmove $RIGHTMOVE ADR (RTMVY.US)$ 54.8%
🇺🇸 Verisign $VeriSign (VRSN.US)$ $50.1%
🇦🇺 Pro Medicus $Pingtan Marine Enterprise (PME.US)$ 49.8%
🇺🇸 NVidia $NVIDIA (NVDA.US)$ 47.3%
🇺🇸 Mastercard $MasterCard (MA.US)$ 45.1%
🇫🇷 GTT $GTT Communications, Inc. (GTTN.US)$ 44.8% ...
Gap Ups
1. $Unum Group (UNM.US)$ - up 5.1%
2. $Generac (GNRC.US)$ - up 5.0%
3. $Builders FirstSource (BLDR.US)$ - up 4.9%
4. $Livent (LTHM.US)$ - up 4.4%
5. $Pearson (PSO.US)$ - up 4.1%
6. $Verisk Analytics (VRSK.US)$ - up 3.6%
7. $Assurant (AIZ.US)$ - up 2.7%
8. $Vodafone (VOD.US)$ - up...
Top Medical News of the Week
Moderna and Merck to develop a cancer vaccine for high-risk melanoma patients
Last week, we had some exciting news on cancer vaccine development announced by Moderna and Merck.
Moderna's vaccine, based on its messenger RNA technology, is being studied in combination with Merck's Keytruda to treat...
But legalizing same-sex marriage is not on the cards, as the government wants to enshrine a ban within its constitution.
If you’re thinking of investing in companies with LGBTQ+ leadership, here are a few options to consider.
1. AAPL $Apple (AAPL.US)$
When looking into LGBTQ+ ESG investing, start with Apple. Tim Co...
No comment yet